EW EDWARDS LIFESCIENCES CORP

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

IRVINE, Calif.--(BUSINESS WIRE)--

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at , with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

EN
07/01/2025

Underlying

EWEDWARDS LIFESCIENCES CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EDWARDS LIFESCIENCES CORP

EW EDWARDS LIFESCIENCES CORP
04/06/26 April 6, 2026 1 EN
Free Trial
EW EDWARDS LIFESCI...

Edwards Lifesciences Corp: 1 director

A director at Edwards Lifesciences Corp sold 24,000 shares at 83.837USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

EW EDWARDS LIFESCIENCES CORP
02/27/26 February 27, 2026 1 EN
EW EDWARDS LIFESCIENCES CORP
12/08/25 December 8, 2025 1 EN
EW EDWARDS LIFESCI...

Moody's Ratings affirms Edwards Lifesciences at Baa2; revises outlook ...

Moody's Ratings (Moody's) affirmed the ratings of Edwards Lifesciences Corporation (Edwards) including the Baa2 senior unsecured notes and Baa2 senior unsecured bank credit facilities. At the same time, we revised the outlook to positive from stable. The rating affirmation reflects our view that E...

EW EDWARDS LIFESCIENCES CORP
08/13/25 August 13, 2025 1 EN
 PRESS RELEASE
Free
EW EDWARDS LIFESCI...

Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Car...

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 45th Annual Health Care Conference on Tuesday, Mar. 4, 2025. Scott Ullem, chief financial officer, is scheduled to present at 9:50 a.m. ET. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at , with an archived version accessible later the same day. About Edwards Lifesciences Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Th...

February 25, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch